LOOMIS SAYLES & CO L P - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$27,152,000
-44.7%
279,004
-44.7%
0.03%
-48.4%
Q1 2021$49,093,000
-15.1%
504,821
-16.3%
0.06%
-15.8%
Q4 2020$57,824,000
+683.6%
603,276
+958.1%
0.08%
+442.9%
Q3 2018$7,379,000
-63.5%
57,017
-69.1%
0.01%
-65.9%
Q2 2018$20,220,000184,5270.04%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders